ClinicalTrials.Veeva

Menu

Effectiveness of Intrapartum Group B Streptococcus (GBS) Polimerase Chain Reaction Reaction (PCR) Screening

B

Baruch Padeh Medical Center

Status

Unknown

Conditions

GBS

Study type

Observational

Funder types

Other

Identifiers

NCT01833780
GBS PCR .CTIL

Details and patient eligibility

About

Study hypothesis: Intrapartum polimeraze chain reaction (PCR)of group B streptoccocus (GBS) test is more accurate than Culture of GBS at 35-37 weeks gestation for GBS carriage.

The investigators will compare GBS culture and PCR results taken at 35-37 weeks gestation to intrapartum PCR GBS and GBS cultures status.

The larger perspective of this trial is to check the possibility of replacing the GBS culture screening program at 35-37 weeks gestation with a more accurate examination (PCR), avoiding the changing GBS carriage status from the time of culture at 35-37 weeks to delivery.

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Unknown GBS pregnant women at 35-37 weeks

Exclusion criteria

  • Known GBS pregnant women at 35-37 weeks

Trial design

0 participants in 2 patient groups

GBS carriage status
GBS status during labor

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems